U.S. Physical Therapy, Inc. (USPH) – What Are Researchers Saying About This Stock?

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $98.25.

A number of brokerages recently commented on USPH. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, September 11th. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. Barrington Research raised their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th.

View Our Latest Stock Analysis on U.S. Physical Therapy

U.S. Physical Therapy Trading Down 1.1%

NYSE USPH opened at $85.63 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a market capitalization of $1.28 billion, a P/E ratio of 503.74, a PEG ratio of 2.20 and a beta of 1.12. The firm’s 50-day moving average is $82.87 and its two-hundred day moving average is $76.92. U.S. Physical Therapy has a 12 month low of $58.19 and a 12 month high of $90.94.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). The company had revenue of $214.06 million for the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. U.S. Physical Therapy’s revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.81 earnings per share. On average, sell-side analysts anticipate that U.S. Physical Therapy will post 2.89 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 11th. Investors of record on Friday, August 21st were paid a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Friday, August 21st. U.S. Physical Therapy’s payout ratio is presently 1,082.35%.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Legal & General Group Plc purchased a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $2,339,000. Renaissance Technologies LLC lifted its position in U.S. Physical Therapy by 23.4% in the first quarter. Renaissance Technologies LLC now owns 76,956 shares of the company’s stock valued at $5,769,000 after acquiring an additional 14,582 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in U.S. Physical Therapy in the second quarter valued at $9,087,000. Royal Bank of Canada grew its holdings in shares of U.S. Physical Therapy by 22.0% during the first quarter. Royal Bank of Canada now owns 133,777 shares of the company’s stock worth $10,029,000 after purchasing an additional 24,081 shares during the last quarter. Finally, BlackRock Inc. acquired a new stake in shares of U.S. Physical Therapy during the second quarter worth about $155,505,000.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.

Featured Articles

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.